P Harmatz Selected Research

Acetylgalactosamine

3/2005

Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P Harmatz Research Topics

Disease

5	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 01/2017 - 03/2004
2	Mucopolysaccharidosis II (Hunter Syndrome) 09/2017 - 12/2009
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 05/2012 - 03/2005
1	Mucopolysaccharidoses 01/2017
1	Disease Progression 01/2017
1	Mucopolysaccharidosis IV (Morquio Syndrome) 09/2013
1	Multiple Sulfatase Deficiency Disease (Mucosulfatidosis) 05/2012
1	Fibrosis (Cirrhosis) 07/2000
1	Sickle Cell Anemia (Hemoglobin S Disease) 07/2000
1	Iron Overload 07/2000

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 09/2013 - 03/2005
3	GlycosaminoglycansIBA 09/2017 - 12/2009
3	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 01/2017 - 03/2004
2	galsulfase FDA Link 01/2017 - 03/2013
2	SulfatasesIBA 09/2013 - 05/2012
1	AntibodiesIBA 09/2017
1	idursulfase FDA Link 09/2017
1	CreatinineIBA 01/2017
1	Dermatan SulfateIBA 01/2017
1	AcetylgalactosamineIBA 03/2005
1	IronIBA 07/2000
1	Ferritins (Ferritin)IBA 07/2000

Therapy/Procedure

6	Enzyme Replacement Therapy 09/2017 - 03/2004
3	Therapeutics 03/2013 - 07/2000
1	Chelation Therapy (Therapy, Chelation) 07/2000
1	Erythrocyte Transfusion 07/2000